There are now a number of approved treatments for patients with cholangiocarcinoma. The Precision-BTC-Network has collaborated with the AMMF to prepare downloadable patient information sheets on several of these treatments (PEMIGATINIB, CEM/CIS/DURVA, IVOSIDENIB), which explain the treatment, how it is administered, for how long, and what side effects might occur and how to deal manage them. To access an information sheet, simply click on the name of the treatment.

This work is complementary to a similar project previously carried out with AMMF in the framework of the COST Action EUROCHOLANGIONET. These patient sheets (FOLFIRI, FOLFOX, GEM CIS, CAPOX, Capecitabine, Gemcitabine) are also included below.

Translations into multiple languages have been created each sheet (also below). The task of translation was carried out thanks to the initiative of Action member Colin Rae and within the framework of a Virtual Mobility (VM) grant.